[4] As of 2013 the company has 58 subsidiaries in Japan, Asia, North and South America and Europe.

[5] In February 2018, the Company entered the endoscope-related business by making Machida Corporation its subsidiary.

[6] In April 1, 2019, the ethical pharmaceutical sales division of subsidiary Nipro ES Pharma Corporation was integrated into the main company’s domestic business division, Pharmaceutical Sales Division.

[7] In April 1, 2023, the Company's head office was relocated to a new building constructed on the Company's own land in Kento Innovation Park in Settsu City.

The registered head offices and the location of the manufacturing and sales office based on the Law Concerning Assurance of Quality, Efficacy and Safety of Pharmaceuticals, Medical Devices and Other Products were scheduled to be relocated in October of the same year.